Literature DB >> 29892930

Angiogenic factors: role in esophageal cancer, a brief review.

Kátia Ladeira1,2,3, Filipa Macedo4, Adhemar Longatto-Filho2,3,5,6,7, Sandra F Martins8,9,10.   

Abstract

Esophageal cancer has an aggressive behavior with rapid tumor mass growth and frequently poor prognosis; it is known as one of the most fatal types of cancer worldwide. The identification of potential molecular markers that can predict the response to treatment and the prognosis of this cancer has been subject of a vast investigation in the recent years. Among several molecules, various angiogenic factors that are linked to the tumor development, growth, and invasion, such as VEGF, HGF, angiopoietin-2, IL-6, and TGF-B1, were investigated. In this paper, the authors sought to review the role of these angiogenic factors in prognosis and hypothesize how they can be used as a treatment target.

Entities:  

Keywords:  Angiopoietin-2; Esophageal cancer; HGF; IL-6; TGF-B1; VEGF

Mesh:

Substances:

Year:  2017        PMID: 29892930     DOI: 10.1007/s10388-017-0597-1

Source DB:  PubMed          Journal:  Esophagus        ISSN: 1612-9059            Impact factor:   4.230


  48 in total

Review 1.  Bevacizumab in non small cell lung cancer.

Authors:  Alan Sandler
Journal:  Clin Cancer Res       Date:  2007-08-01       Impact factor: 12.531

2.  Significance of transforming growth factor beta1 as a new tumor marker for colorectal cancer.

Authors:  Shin Narai; Masahiko Watanabe; Hirotoshi Hasegawa; Hideki Nishibori; Takashi Endo; Tetsuro Kubota; Masaki Kitajima
Journal:  Int J Cancer       Date:  2002-02-01       Impact factor: 7.396

Review 3.  Angiogenesis-related factors are molecular targets for diagnosis and treatment of patients with esophageal carcinoma.

Authors:  Yoko Oshima; Satoshi Yajima; Kunihiro Yamazaki; Kazuyuki Matsushita; Masatoshi Tagawa; Hideaki Shimada
Journal:  Ann Thorac Cardiovasc Surg       Date:  2010-12       Impact factor: 1.520

4.  Concurrent overexpression of Ets-1 and c-Met correlates with a phenotype of high cellular motility in human esophageal cancer.

Authors:  Hiroshi Saeki; Shinya Oda; Hidetoshi Kawaguchi; Shinji Ohno; Hiroyuki Kuwano; Yoshihiko Maehara; Keizo Sugimachi
Journal:  Int J Cancer       Date:  2002-03-01       Impact factor: 7.396

Review 5.  Interleukin-6 signaling pathway in targeted therapy for cancer.

Authors:  Yuqi Guo; Feng Xu; TianJian Lu; Zhenfeng Duan; Zhan Zhang
Journal:  Cancer Treat Rev       Date:  2012-05-29       Impact factor: 12.111

Review 6.  The hypoxic tumor microenvironment and gene expression.

Authors:  Cornelia Leo; Amato J Giaccia; Nicholas C Denko
Journal:  Semin Radiat Oncol       Date:  2004-07       Impact factor: 5.934

7.  Plasma level of transforming growth factor beta1 measured from the azygos vein predicts prognosis in patients with esophageal cancer.

Authors:  Minoru Fukuchi; Tatsuya Miyazaki; Yasuyuki Fukai; Masanobu Nakajima; Makoto Sohda; Norihiro Masuda; Ryokuhei Manda; Katsuhiko Tsukada; Hiroyuki Kato; Hiroyuki Kuwano
Journal:  Clin Cancer Res       Date:  2004-04-15       Impact factor: 12.531

8.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

9.  High levels of transforming growth factor beta 1 in patients with colorectal cancer: association with disease progression.

Authors:  H Tsushima; S Kawata; S Tamura; N Ito; Y Shirai; S Kiso; Y Imai; H Shimomukai; Y Nomura; Y Matsuda; Y Matsuzawa
Journal:  Gastroenterology       Date:  1996-02       Impact factor: 22.682

10.  Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus.

Authors:  Shoji Natsugoe; Che Xiangming; Masataka Matsumoto; Hiroshi Okumura; Saburo Nakashima; Hironori Sakita; Sumiya Ishigami; Masamichi Baba; Sonshin Takao; Takashi Aikou
Journal:  Clin Cancer Res       Date:  2002-06       Impact factor: 12.531

View more
  8 in total

1.  Co-administration of platelet-rich plasma and small intestinal submucosa is more beneficial than their individual use in promoting acute skin wound healing.

Authors:  Xiaoxuan Lei; Liuhanghang Cheng; Yu Yang; Mengru Pang; Yunqing Dong; Xuanru Zhu; Caihong Chen; Zexin Yao; Gang Wu; Biao Cheng; Tymour Forouzanfar
Journal:  Burns Trauma       Date:  2021-11-30

2.  Low expression of LncRNA-CAF attributed to the high expression of HIF1A in esophageal squamous cell carcinoma and gastric cancer patients.

Authors:  Shabbou Bahramian; Reza Sahebi; Zahra Roohinejad; Encieh Delshad; Naeme Javid; Abolfazl Amini; Amirnader Emami Razavi; Mohammad Shafiee; Fatemeh T Shamsabadi
Journal:  Mol Biol Rep       Date:  2022-01-18       Impact factor: 2.316

3.  Potential Role of circPVT1 as a proliferative factor and treatment target in esophageal carcinoma.

Authors:  Rongrong Zhong; Zhuozhi Chen; Ting Mo; Zimo Li; Peng Zhang
Journal:  Cancer Cell Int       Date:  2019-10-15       Impact factor: 5.722

Review 4.  Cytokine Interaction With Cancer-Associated Fibroblasts in Esophageal Cancer.

Authors:  Md Sazzad Hassan; Nicholas Cwidak; Niranjan Awasthi; Urs von Holzen
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

5.  MYBL1 induces transcriptional activation of ANGPT2 to promote tumor angiogenesis and confer sorafenib resistance in human hepatocellular carcinoma.

Authors:  Jinrong Zhu; Yongqi Wu; Yijian Yu; Yan Li; Jianfei Shen; Rongxin Zhang
Journal:  Cell Death Dis       Date:  2022-08-20       Impact factor: 9.685

6.  HOXB5-activated ANGPT2 promotes the proliferation, migration, invasion and angiogenic effect of esophageal cancer cells via activating ERK/AKT signaling pathway.

Authors:  Jing Li; Shanshan Gao
Journal:  Exp Ther Med       Date:  2022-07-20       Impact factor: 2.751

Review 7.  Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment.

Authors:  Raluca Ioana Teleanu; Cristina Chircov; Alexandru Mihai Grumezescu; Daniel Mihai Teleanu
Journal:  J Clin Med       Date:  2019-12-29       Impact factor: 4.241

8.  Combined detection of peripheral blood VEGF and inflammation biomarkers to evaluate the clinical response and prognostic prediction of non-operative ESCC.

Authors:  Yuanyuan Ma; Xinyu Su; Xin Li; Xiaohui Zhi; Kan Jiang; Jianhong Xia; Hongliang Li; Chen Yan; Liqing Zhou
Journal:  Sci Rep       Date:  2021-07-27       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.